Research Funding

DOD Prostate Cancer Research Program Funding Opportunity Fiscal Year 2019

The FY19 Defense Appropriation provides $100 million (M) to the Department of Defense Prostate Cancer Research Program (PCRP) to support innovative, high-impact prostate cancer research.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate, manages the Defense Health Program Research, Development, Test, and Evaluation appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

FY19 PCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

The mission of the PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all the men and their families who are experiencing the impact of the disease.  Applications submitted to the FY19 PCRP must address one or more of the program’s Overarching Challenges:

  • Improve the quality of life for survivors of prostate cancer
  • Develop treatments that improve outcomes for men with lethal prostate cancer
  • Reduce lethal prostate cancer in African Americans, Veterans, and other high-risk populations
  • Define the biology of lethal prostate cancer to reduce death

https://cdmrp.army.mil/funding/pcrp

Early Investigator Research Award

By March 31, 2020, Postdoctoral Principal Investigators (PIs):

  • Must possess a doctoral degree (or equivalent)
  • Have 3 years or less of postdoctoral research experience (excluding clinical residency or clinical fellowship training)
  • Supports research opportunities focused on prostate cancer for individuals in the early stages of their careers.
  • PIs must have a designated mentor who is an experienced prostate cancer researcher.
  • Applications from PIs who demonstrate a commitment to pursuing a career focused in prostate cancer health disparity research are highly encouraged.
  • Must address at least one of the FY19 PCRP Overarching Challenges.
  • Maximum of $200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is

Physician Research Award

At the time of application submission, the PI must be either:

  • In the last year of an accredited graduate medical education program, either as a resident fellow:
  • or
  • Within 5 years of having initiated a faculty appointment (including Instructor positions)
  • Supports a mentored research experience to prepare physicians with clinical duties for careers in prostate cancer research.
  • PIs must demonstrate a commitment to a career at the forefront of prostate cancer research and clinical practice.
  • PIs must have a designated mentor with an established research program in prostate cancer.
  • Must address at least one of the Fy19 PCRP Overarching Challenges.
  • Maximum funding of $750K for direct costs (plus indirect costs).
  • Maximum period of performance is 4

Idea Development Award

Established Investigators:  Independent investigators at all levels

Or

New Investigators:  Investigators that meet the following criteria at the application submission deadline date:

  • Have the freedom to pursue individual aims without formal mentorship
  • Have not previously received a PCRP Health Disparity Research Award and/or Idea Development Award
  • Have either completed at least 3 years of postdoctoral training or fellowship or are within 10 years after completion of terminal degree (excluding residency or family leave)
  • Preproposal is required; application submission is by invitation only.
  • Supports new ideas that represent innovative, high-risk/high-gain approaches to prostate cancer research and have the potential to make an important contribution to one or more of the FY19 PCRP Overarching Challenges.
  • Emphasis is equally placed on Innovation and Impact.
  • Preliminary data are encouraged, but not required.
  • Clinical trials are not allowed.
  • Must address at least one of the Fy19 PCRP Overarching Challenges.
  • Each PI may submit only one application.
  • New Investigator Option supports applicants early in their faculty appointments or in the process of developing independent research careers
  • Established Investigators:
  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • New Investigators:
  • Maximum funding of $600,000 for direct costs (plus indirect costs)
  • Maximum period of performance is years

 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.